Enlivex Ltd. - (ENLV) closed at $1.25 on November 12, 2026, down 1.2% from the previous close, on volume of 20,278 shares (30-day average 1,622,186).
Data as of November 12, 2026.
Globe Newswire (Mon, 2-Nov 8:00 AM ET)
Globe Newswire (Wed, 28-Oct 8:00 AM ET)
Enlivex Announces Receipt of Delisting Notice from Nasdaq; Intends to Appeal
Globe Newswire (Tue, 27-Oct 8:00 AM ET)
Enlivex Announces 1-for-16 Reverse Share Split to be Effective October 27, 2026
Globe Newswire (Thu, 22-Oct 5:16 PM ET)
Globe Newswire (Mon, 19-Oct 8:17 AM ET)
Enlivex Announces Termination of Previously-Announced Financing Payable in RAIN Tokens
Globe Newswire (Tue, 22-Sep 8:00 AM ET)
ENLV Secures $400 Million Private Placement—Major Bet on Prediction Markets and Longevity Medicine
Market Chameleon (Tue, 28-Jul 5:23 AM ET)
Market Chameleon (Mon, 13-Jul 4:30 AM ET)
Market Chameleon (Wed, 25-Mar 6:33 AM ET)
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
Enlivex Ltd. - trades on the NASDAQ stock market under the symbol ENLV.
As of November 12, 2026, ENLV stock price declined to $1.25 with 20,278 million shares trading.
ENLV has a beta of 1.16, meaning it tends to be more sensitive to market movements. ENLV has a correlation of 0.01 to the broad based SPY ETF.
ENLV has a market cap of $1.91 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, ENLV traded as high as $1,101.60 and as low as $1.18.
ENLV has underperformed the market in the last year with a price return of -99.5% while the SPY ETF gained +12.0%. ENLV has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -95.9% and -52.3%, respectively, while the SPY returned -1.5% and -2.0%, respectively.
ENLV support price is $1.13 and resistance is $1.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ENLV shares will trade within this expected range on the day.
